With yesterday's Supreme Court decision to uphold the Affordable Care Act, health care has certainly dominated the headlines this week. With that in mind, today I'm highlighting another huge health care decision from this week--on Tuesday, the Senate passed the FDA Safety and Innovation Act, which reauthorizes the Prescription Drug User Fee Act. Here's what some are saying about the Senate vote:

• An article in the Washington Post emphasizes the Safety and Innovation Act's bipartisan support.
• In a release from the American Pharmacists Association, a representative hailed PDUFA, as "the year's most bipartisan legislation to date."
• The American Society of Hematology released a statement outlining the importance of the bill for addressing the drug shortages.
• "Consumers and drug companies alike should cheer a new bill, likely to be soon signed into law, that gives the agency more funding in the form of fees from the companies it regulates," reads an article from Forbes.

Next week, President Obama is expected to sign the legislation into law. Stay tuned as we continue to look at ways that policy can help bring innovative medicines to patients more efficiently.